ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1001 • 2017 ACR/ARHP Annual Meeting

    Persistence, Discontinuation, and Switching Patterns Among Ankylosing Spondylitis Patients Newly Initiating Biologic Therapy

    Theresa Hunter1, Krista Schroeder2, Sarah Al Sawah2 and David Sandoval Calderon2, 1Global Patient Outcomes and Real World Evidence, Eli Lilly and Company, Indianapolis, IN, 2Eli Lilly and Company, Indianapolis, IN

    Background/Purpose: The primary goals of treating Ankylosing Spondylitis (AS) patients are to maximize long-term health-related quality of life through control of symptoms and inflammation, prevention…
  • Abstract Number: 1002 • 2017 ACR/ARHP Annual Meeting

    Survival and Years of Potential Life Lost in Connective Tissue Disease and Vasculitis; Data from the Norwegian Connective Tissue Diseases and Vasculitis Registry (NOSVAR)

    Torhild Garen1, Karoline Lerang1, Anna Maria Hoffmann-Vold2, Helena Andersson1, Øyvind Midtvedt1, Karin Kilian1, Ragnar Gunnarsson1, Birgir Gudbrandsson1, Gudrun Norby1, Oyvind Molberg2 and Øyvind Palm1, 1Department of Rheumatology, Oslo University Hospital, Oslo, Norway, OSLO, Norway, 2Department of Rheumatology, Oslo University Hospital, Oslo, Norway, Oslo, Norway

    Background/Purpose: Survival is decreased in patients with connective tissue diseases (CTDs) and vasculitis, however few studies have compared the mortality between the specific diseases prospectively…
  • Abstract Number: 1003 • 2017 ACR/ARHP Annual Meeting

    Hair Treatments and the Risk of Systemic Lupus Erythematosus:  the Michigan Lupus Epidemiology & Surveillance (MILES) Program

    Emily C. Somers1, Christina Mrukowicz2, Wendy Marder1, W. Joseph McCune3, Afton L. Hassett4, Suzanna Zick5, Siobán Harlow6 and Caroline Gordon7, 1Internal Medicine-Rheumatology, University of Michigan, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI, 3Int Med/ Rheum, University of Michigan, Ann Arbor, MI, 4Rheumatology, Emory University, Atlanta, GA, 5Department of Family Medicine, University of Michigan, Ann Arbor, MI, 6Epidemiology Department- School of Public Health, Obstetrics and Gynecology- Medical School, University of Michigan, Ann Arbor, MI, 7School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

    Background/Purpose: Hair dye exposure has been reported as a risk factor for systemic lupus erythematosus (SLE) and connective tissue diseases, though conflicting results exist. We…
  • Abstract Number: 1004 • 2017 ACR/ARHP Annual Meeting

    Arthritis Impact at the State and County Level — United States, 2015

    Kamil E. Barbour1, Suson Moss2, Janet Croft2, Jennifer M. Hootman3, Louise Murphy4, Kristina Theis2, Yan Wang2, Hua Lu2, Teresa J. Brady1 and Charles G. Helmick2, 1Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3Centers for Disease Control and Prevention, Kennesaw, GA, 4Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose: Arthritis, a leading cause of disability, affects 54.4 million US adults. By knowing the state and county level arthritis impact, state-level public health professionals…
  • Abstract Number: 1005 • 2017 ACR/ARHP Annual Meeting

    The Prevalence of Patellofemoral Osteoarthritis in China: A Multi-Center Population-Based Cross-Sectional Study

    Zhanglai Li1, Qiang Liu1, Changsheng Zhao2, Yuqing Zhang3, Xiaowei Li1 and Jianhao Lin1, 1Arthritis Clinic and Research Center, Peking University People's Hospital,Peking University, Beijing, China, 2Peking University International Hospital, Peking University International Hospital, Beijing, China, 3School Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: To describe the prevalence and risk factors of patellofemoral osteoarthritis (OA) in a Chinese population.Methods: A multi-center population-based cross-sectional survey was conducted in 2015…
  • Abstract Number: 1006 • 2017 ACR/ARHP Annual Meeting

    Sex Differences in Depressive Symptom Subtypes in Knee Osteoarthritis

    Alan Rathbun1, Megan Schuler2, Elizabeth Stuart3, Michelle Shardell4, Michelle S. Yau5 and Marc Hochberg6, 1Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, 2Rand Coportation, Boston, MA, 3Mental Health, Biostatistics, and Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 4Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, 5Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, 6Department of Medicine, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Knee osteoarthritis (OA) is characterized by structural changes in subchondral bone and degradation of articular cartilage, but the pathology does not necessarily lead to…
  • Abstract Number: 1007 • 2017 ACR/ARHP Annual Meeting

    Smoking Signicantly Reduces Effectiveness and Long-Term Survival of Biologic Treatment in Patients with Rheumatoid Arthritis

    Roger Rolon Campuzano1, Andrea Lujan Coronel Ale1, Osvaldo Luis Cerda1, Fernando Dal Pra1, Emilce E Schneeberger1, María de los Angeles Correa2, Marcos Rosemffet1, Emilio Buschiazzo3, Rodrigo Garcia Salinas4, Silvia Papasidero5, Belén Barrios5, Hernán Maldonado Ficco6 and Gustavo Citera7, 1Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, 2Section Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, 3Section of Rheumatology, Hospital Señor del Milagro, Salta, Argentina, Salta, Argentina, 4Section of Rheumatology, Hospital Italiano de La Plata, Buenos Aires, Argentina, La Plata, Argentina, 5Section of Rheumatology, Hospital General de Agudos “Dr. E. Tornú”, Buenos Aires, Argentina, Buenos Aires, Argentina, 6section of Rheumatology, Clinica Regional del Sud, Córdoba, Argentina, Córdoba, Argentina, 7Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina

    Background/Purpose: The introduction of biological agents has been an important advance in the treatment of RA. However, they are not exempt from adverse events and…
  • Abstract Number: 1008 • 2017 ACR/ARHP Annual Meeting

    mtDNA Cybrids from OA Patients Are Less Efficient Using Glycolysis and Are More Susceptible to Apoptosis Under Stress Conditions

    Mercedes Fernandez Moreno1,2, Tamara Hermida-Gómez3, Andrea Dalamao-Fernandez4, M. Eugenia Vazquez Mosquera4, Estefanía Cortés-Pereira1, Morena Scotece4, Sara Relaño-Fernandez5, Ignacio Rego-Pérez1 and Francisco J Blanco6, 1Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2CIBER-BBM, Madrid, Spain, 3Rheumatology, INIBIC. Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. CIBER-BBN., A Coruña, Spain, 4Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A CORUÑA, Spain, 5Plataforma de Genómica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña. España, A Coruña, Spain

    Background/Purpose:  Previous studies have showed that chondrocytes from OA patients had mitochondrial alteration in comparison with healthy. However the role of mitochondria in the biological…
  • Abstract Number: 1009 • 2017 ACR/ARHP Annual Meeting

    Novel Non-Coding RNAs Associated with Rheumatoid Arthritis in Asians By Gene-Based Testing

    Aleksander Lenert1 and David W. Fardo2, 1Internal Medicine, Div. of Rheumatology, University of Kentucky, Lexington, KY, 2Biostatistics, College of Public Health, University of Kentucky, Lexington, KY

    Background/Purpose: Rheumatoid arthritis (RA) is a complex genetics disease driven by multiple genetic contributors as evidenced by association with over 100 risk SNPs by GWAS.…
  • Abstract Number: 1010 • 2017 ACR/ARHP Annual Meeting

    Identification of Circulating Biomarkers of Disease Activity and Organ Involvement in ANCA-Associated Vasculitis By Targeted Proteomics

    Jun Ishizaki1, Ayako Takemori2, Koichiro Suemori1, Takuya Matsumoto1, Yoko Akita1, Masaki Yasukawa1, Nobuaki Takemori2 and Hitoshi Hasegawa1, 1Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan, 2Division of Proteomics Research, Proteo-Science Center, Ehime University, Ehime, Japan

    Background/Purpose: Targeted proteomics, which involves quantitative analysis of targeted proteins using selected reaction monitoring (SRM) mass spectrometry, has emerged as a new methodology for discovery…
  • Abstract Number: 1011 • 2017 ACR/ARHP Annual Meeting

    Mitochondrial Haplogroups-Mediated Methylation Regulates Apoptosis in Osteoathritis Cartilage

    Ignacio Rego-Pérez1, Estefanía Cortés-Pereira1, Juan Fernández-Tajes Sr.2, Mercedes Fernandez Moreno1, Maria Eugenia Vazquez Mosquera1, Sara Relaño-Fernandez3, Natividad Oreiro4, Carlos Fernandez-Lopez1 and Francisco J Blanco1, 1Servicio de Reumatología. Area Genomica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2The Wellcome Trust Center for Human Genetics. McCarthy´s Group. University of Oxford, Oxford, United Kingdom, 3Plataforma de Genómica. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 41) Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruna, Spain

    Background/Purpose: Recent studies revealed that haplogroup J associates with a decreased rate of incident knee Osteoarthritis. Among the functional characteristics of this haplogroup, lower rates…
  • Abstract Number: 1012 • 2017 ACR/ARHP Annual Meeting

    Analysis of microRNAs in Familial Mediterranean Fever

    Gil Amarilyo1, Nir Pillar2, Ilan Ben-Zvi3, Daphna Weissglas-Volkov2, Jonatan Zalcman2, Liora Harel4, Avi Livneh3 and Noam Shomron2, 1Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel, 2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 3Chaim Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 4Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Background/Purpose: Familial Mediterranean fever (FMF) is thought to be inherited as an autosomal recessive trait. However, there are frequent deviations from this model. The aim…
  • Abstract Number: 1013 • 2017 ACR/ARHP Annual Meeting

    HLA-Class II Associations with ANCA-Associated Vasculitis in the Japanese Population: Different Features from European Populations

    Aya Kawasaki1, Fumio Hirano2, Ken-ei Sada3, Shigeto Kobayashi4, Hidehiro Yamada5, Hiroshi Furukawa1, Kenji Nagasaka6, Takahiko Sugihara7, Kunihiro Yamagata8, Takayuki Sumida9, Shigeto Tohma10, Shoichi Ozaki5, Seiichi Matsuo11, Hiroshi Hashimoto12, Hirofumi Makino13, Yoshihiro Arimura14, Masayoshi Harigai15 and Naoyuki Tsuchiya1, 1Molecular and Genetic Epidemiology Laboratory, University of Tsukuba, Faculty of Medicine, Tsukuba, Japan, 2Departments of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 3Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 4Department of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan, 5Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 6Department of Rheumatology, Ome Municipal General Hospital, Ome, Japan, 7Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 8Department of Nephrology, University of Tsukuba, Faculty of Medicine, Tsukuba, Japan, 9Department of Internal Medicine, University of Tsukuba, Faculty of Medicine, Tsukuba, Japan, 10Clinical Research Center for Allergy and Rheumatology, Sagamihara Hospital, National Hospital Organization, Sagamihara, Japan, 11Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 12Juntendo University School of Medicine, Tokyo, Japan, 13Okayama University Hospital, Okayama, Japan, 14First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan, 15Division of Epidemiology and Pharmacoepidemiology of Rheumatic Diseases, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: HLA-class II region harbors the strongest genetic factors for ANCA-associated vasculitis (AAV), and differences in the genetic background of HLA-class II may partly explain…
  • Abstract Number: 1014 • 2017 ACR/ARHP Annual Meeting

    The Rheumatic Disease Data Refinery: A Case Study in Integrative Genomics Reveals Complex IFN Signatures in Therapeutic Studies in SLE

    Jaclyn N Taroni and Casey S. Greene, Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Over the past 15 years, more than 10,000 whole tissue biopsies from patients with rheumatic diseases have been deposited into publicly available gene expression…
  • Abstract Number: 1015 • 2017 ACR/ARHP Annual Meeting

    Key Genes and Pathways between Rheumatoid Arthritis and Osteoarthritis By Integrative Genome-Wide Gene Expression Profiling Analysis

    Rongqiang Zhang1,2, Aimin Yang3, Xiaomei Ren2, Jie Zhang3, Xiaoli Yang4, Qiling Liu2, Na Sun2, Puwei Yuan5 and Yongmin Xiong4, 1School of Public Health, Xi'an Jiaotong University Health Science Center, Key Laboratory of Trace Elements and Endemic Diseases of the National Health and Family Planning Commission, Xi'an 710061, China, Xi'an, China, 2Shaanxi University of Chinese Medicine, Xianyang 712046, China, Xianyang, China, 3School of Public Health, Brown University, Providence, RI 02906, US, Providence, RI, 4School of Public Health, Xi'an Jiaotong University Health Science Center, Key Laboratory of Trace Elements and Endemic Diseases of the National Health and Family Planning Commission, Xi'an 710061, China, Xian, China, 5Shaanxi University of Chinese Medicine, Xianyang 712046, China, XianYang, China

    Background/Purpose: Rheumatoid arthritis (RA) and Osteoarthritis (OA) are two most common types of joint diseases with lots of similar symptoms, and their pathological mechanisms remain…
  • « Previous Page
  • 1
  • …
  • 1452
  • 1453
  • 1454
  • 1455
  • 1456
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology